Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect

This publication has 29 references indexed in Scilit:

• TOR, a Central Controller of Cell Growth
  Cell, 2000
• Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression
  Clinical Biochemistry, 1998
• Rapamycin and p53 act on different pathways to induce G1 arrest in mammalian cells
  Oncogene, 1997
• The proto-oncogene Bcl-2 and its role in regulating apoptosis
  Nature Medicine, 1997
• RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs
  Cell, 1994
• A mammalian protein targeted by G1-arresting rapamycin–receptor complex
  Nature, 1994
• The Bcl-2 Protein: a Prognostic Indicator Strongly Related to p53 Protein in Lymph Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1994
• Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression
  Cell, 1993
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome Translocation
  Science, 1984